Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 7/20 | 0.62 |
| ▸ | TP53 | P04637 | 5/20 | 0.61 |
| ▸ | THRB | P10828 | 3/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24619803 | 0.96 | LMNA (0.68) | LMNAMAPTTP53THRBPOLB | |
| SCHEMBL24741269 | 0.88 | LMNA (0.68) | LMNAMAPTTP53THRBPOLB | |
| SCHEMBL24619961 | 0.87 | TP53 (0.66) | LMNAMAPTTP53THRBPOLB | |
| Formic Acid SCHEMBL29925480 | 0.86 | MAPT (0.58) | LMNAMAPTTP53THRBPOLB | |
| SCHEMBL24741290 | 0.86 | LMNA (0.67) | LMNAMAPTTP53THRBPOLB | |
| SCHEMBL24619719 | 0.85 | LMNA (0.68) | LMNAMAPTTP53THRB | |
| SCHEMBL29924744 | 0.85 | MAPT (0.85) | LMNAMAPTTP53THRBPOLB | |
| SCHEMBL24619398 | 0.85 | MAPT (0.85) | LMNAMAPTTP53THRBPOLB | |
| Formic Acid SCHEMBL30537906 | 0.84 | SLC2A1 (0.58) | LMNAMAPTTP53THRBPOLB | |
| SCHEMBL24741002 | 0.84 | MAPT (0.84) | LMNAMAPTTP53THRBPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4274569-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2023-11-15 | — | — | EP | disclosed |
| CN-116635028-A | Modulators of c-MYC mRNA translation and their use in the treatment of cancer | 艾尼莫生物科技公司 | 2023-08-22 | — | — | CN | disclosed |
| WO-2022150316-A1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2022-07-14 | — | — | WO | disclosed |